SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly results beat expectations and raised guidance, with a large revenue backlog and customer prepayments bolstering the AI-compute demand story and easing some financing concerns. The community reaction is split: bulls see stronger execution and potential short covering, while bears remain focused on heavy debt, interest costs and cash burn; the stocks muted, volatile response drew particular attention.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and outlook are driving attention, with traders focused on improved profitability and recurring Samsung and Micron licensing revenue expected to bolster future quarters. The reaction is mostly bullish, though some question the decline in product sales and are disappointed that the call provided no concrete SK Hynix or Nasdaq-uplisting update; speculation about a Hynix deal remains unconfirmed.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the Nov. 22 FDA decision on Capricors deramiocel application for Duchenne muscular dystrophy; management said the application is in final review and described launch preparations. Many traders read CEO Linda Marbns confident Q3-call remarks as encouraging, while others caution that the outcome remains uncertain given FDA concerns and the applications binary risk.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Scrutiny of CEO Jensen Huang over his relationship with a woman alleged to have ties to Chinese intelligenceand questions about Nvidia chip shipments to Chinais driving concern about governance, export controls, and whether Huang could remain CEO; the allegations have not established that company secrets were compromised. Traders are split between viewing the selloff as an oversold buying opportunity ahead of earnings and fearing further fallout from the investigations and shareholder litigation.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis Q3 results missed expectations, particularly on revenue, prompting a sharp selloff and renewed criticism of its high valuation, cash burn, and slow path to commercialization. Some traders remain optimistic about its quantum technology and long-term prospects, but that view is competing with concerns that technical progress and government support have yet to translate into meaningful business growth.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos announcement of a large special cash dividend and renewed share-buyback authorization is driving the discussion. Many traders welcome the shareholder payout and are bullish on the stock, while others argue the dividend is not free money and that Costcos valuation remains expensive.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius quarterly results are driving attention: revenue growth, expanding gross margins and raised full-year guidance were offset by an EPS miss and weaker-than-expected adjusted EBITDA, prompting a sharp selloff. Bulls view the reaction as an overreaction to the miss and emphasize the growth outlook, while more cautious traders point to continued losses and near-term risks.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Waves Q3 report is driving the discussion: traders are weighing revenue growth and a sizable backlog against softer bookings, continued losses, and questions about turning orders into revenue, amid a sharp selloff. Bulls point to D-Waves commercial potential and cash reserves, while bears argue its valuation remains stretched and near-term demand is unproven.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Strong Q3 results and another increase to full-year revenue guidance drove a sharp rally in SENS, with traders pointing to accelerating Eversense CGM adoption. The gains then faded, prompting debate between bullish holders who see improving commercial momentum and skeptics citing profit-taking, cash needs, and management or dilution risks.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins quarterly results, particularly improved profitability and a new share-buyback authorization, are driving discussion. Traders are split: some see stronger margins and repurchases as bullish, while others point to declining same-store sales and a muted, range-bound share price; hopes for a U.S. relisting remain speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?

The Trade Desk expands healthcare advertising with OptimizeRx, adding authenticated HCP inventory across 400+ EHR and e-prescribing systems.

OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network

Equity

The move gives life sciences advertisers a more streamlined way to bring specialized healthcare audiences into their broader digital media strategies.



OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

OptimizeRx (OPRX) delivered earnings and revenue surprises of +45.46% and +0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

PTC Inc. (PTC) Q3 Earnings and Revenues Miss Estimates

PTC Inc. (PTC) delivered earnings and revenue surprises of -1.25% and -2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Commvault Systems (CVLT) Beats Q1 Earnings and Revenue Estimates

Commvault (CVLT) delivered earnings and revenue surprises of +20.34% and +0.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pegasystems (PEGA) Lags Q2 Earnings and Revenue Estimates

Pegasystems (PEGA) delivered earnings and revenue surprises of -18.61% and -1.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.

OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

OptimizeRx Corp

Bullish Sentiment

<ul class="summary-bullets"><li>OptimizeRx’s network spans more than 400 EHR and e-prescribe systems.</li><li>EHR advertising has traditionally relied on direct managed-service relationships or specialized healthcare platforms.</li><li>The inventory is expected to become available through OpenPath in the fourth quarter of 2026.</li></ul>OptimizeRx Corp. (OPRX) on Tuesday announced an integration with OpenPath, The Trade Desk’s supply path optimization solution, which will make the firm’s authenticated point-of-care inventory directly available to advertisers using The Trade Desk’s (TTD) demand-side platform.&nbsp;The company said its network covers more than 400 EHR and e-prescribe systems and reaches 800,000 verified healthcare professionals.At the time of writing, OPRX was up nearly 1%, while TTD shares were down about 4%.<h2 class="st-heading-2">Expanding Programmatic Access</h2>OptimizeRx said EHR advertising inventory has historically been purchased mainly through direct managed-service relationships or specialized healthcare platforms.The integration will allow advertisers to use The Trade Desk’s existing programmatic buying infrastructure when accessing OptimizeRx’s inventory, bringing it into the same buying environment as other digital media.Stephen Silvestro, CEO of OptimizeRx, said that by integrating with OpenPath, the firm can make its authenticated clinical inventory directly accessible to a broader base of advertisers using The Trade Desk.OptimizeRx said its offering is differentiated by its connection to verified healthcare providers, real clinical workflows, and proximity to treatment decisions.Baron Harper, VP of Business Development at The Trade Desk, said the integration gives life sciences advertisers more choice in accessing differentiated healthcare inventory.<h2 class="st-heading-2">Part Of Broader Distribution Strategy</h2>The company described the integration as the latest step in its broader programmatic distribution strategy for its proprietary EHR network. OptimizeRx said creating multiple buyer entry points can help it reach new sources of advertiser demand while giving life sciences marketers greater flexibility in accessing its EHR inventory.OptimizeRx said its EHR point-of-care inventory is expected to become available to advertisers using The Trade Desk through OpenPath in the fourth quarter of 2026.<h2 class="st-heading-2">ORPX, TTD: Retail View</h2>Retail sentiment toward OPRX on Stocktwits was “neutral” amid high message volume over the past 24 hours. Sentiment toward TTD remained “bearish,” with the stock also ranking among Stocktwits’ trending tickers.<a href="https://stocktwits.com/symbol/OPRX">OPRX</a> shares are down about 38% year-to-date, while&nbsp;<a href="https://stocktwits.com/symbol/TTD">TTD&nbsp;</a>shares have declined about 65% over the same period.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/twin-moves-vrtx-rises-on-kidney-disease-trial-results-maze-rallies-harder/cZMPusmRB7c">Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies Harder</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Trade Desk logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The move gives life sciences advertisers a more streamlined way to bring specialized healthcare audiences into their broader digital media strategies.

Trade Desk Inc

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Stocktwits Polls

$OPRX with a textbook technical expansion today. That multi-week consolidation under the $9.05 pivot finally broke, printing an intraday high of $9.60 (+5.4%). The key now into the close is converting prior supply at $9.05 into a structural demand shelf. If $9.05 holds on backtests, the path of least resistance clears toward the next liquidity pocket at $10.50–$11.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

OPRX OptimizeRx Corp

Fundamentals

Latest OPRX News